CTD // Fund
Cell Innovation Partners
Life sciences sector focused VC firm investing in geographies such as Australia, Belgium and Taiwan
← Fund directoryCell Innovation Partners
JapanCell Innovation Partners is an institutional investor (Conventional VCs) founded in 2014 and headquartered in Yokohama, Japan. Cell Innovation Partners is a venture capital firm. Geographies of interest include Australia, Belgium, and Taiwan. Typically invests in life sciences sectors such as Biopharma and Biotech. Notable portfolio companies include Promethera, Elastagen, Steminent Biotherapeutics. Notable portfolio companies: Promethera, Elastagen, Steminent Biotherapeutics.
- Stage
- growth, pre-IPO, growth, pre-IPO
- Check size
- $0.5M-$1M
- HQ
- Yokohama, Japan
- Founded
- 2014
- Website
- http://cell-ip.com
- LinkedIn
- https://linkedin.com/company/lifecore-partners-inc
Institutional Investorstem celliPS cellsregenerative medicinecell therapy
What they look for
bio-ventures developing pluripotent/iPS cells and regenerative medicine technologies with high growth potential expected to enter business phase in 5-7 years; geography: Japan, US, EU
📊 Valuation calculator for deal screening — free tool using revenue multiples by sector and round.
⚠️ Common pitch mistakes we see →
Preparing to pitch Cell Innovation Partners?
CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.
Analyze My Deck →